New perspectives in cAMP-signaling modulation

Current Heart Failure Reports

Volumn 8, Issue 3, 2011, Pages 159-167

  Berthouze, Magali ^a,b   Laurent, Anne Coline ^a,b,c   Breckler, Magali ^a,b,c   Lezoualc'h, Frank ^a,b  

^a University Hospital of Toulouse   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Adrenergic receptor; A kinase anchoring proteins; AKAP; Compartmentalization; Epac; Exchange proteins directly activated by cAMP; G protein coupled receptor; GPCR; Heart failure; Investigative therapy; Phosphodiesterases; PKA; Protein kinase A; Small G protein

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC GMP; MITOGEN ACTIVATED PROTEIN KINASE 7; PHOSPHODIESTERASE; PHOSPHODIESTERASE III; PHOSPHODIESTERASE IV; PROTEIN KINASE C; ROFLUMILAST; SCAFFOLD PROTEIN;

CELLULAR DISTRIBUTION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HEART FAILURE; HUMANS; MYOCYTES, CARDIAC; PHOSPHORIC DIESTER HYDROLASES; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, CCR10; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 80055054820     PISSN: 15469530     EISSN: 15469549     Source Type: Journal    
DOI: 10.1007/s11897-011-0062-8     Document Type: Review

References (56)

1. Bers DM. Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol. 2008;70:23-49. (Pubitemid 351738170)
2. Movsesian MA, Bristow MR. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Curr Top Dev Biol. 2005;68:25-48. (Pubitemid 43588862)
3. Lohse MJ, Engelhardt S, Eschenhagen T. What is the role of beta-adrenergic signaling in heart failure? Circ Res. 2003;93:896-906. (Pubitemid 37433227)
4. Fischmeister R, Castro LR, Abi-Gerges A, et al. Compartmentalization of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases. Circ Res. 2006;99:816-828. (Pubitemid 44556380)
5. Houslay MD. Underpinning compartmentalised cAMP signaling through targeted cAMP breakdown. Trends Biochem Sci. 2010;35:91-100.
6. Scott JD, Santana LF. A-kinase anchoring proteins: getting to the heart of the matter. Circulation. 2010;121:1264-1271.
7. Gloerich M, Bos JL. Epac: defining a new mechanism for cAMP action. Annu Rev Pharmacol Toxicol. 2010;50:355-375.
8. Lompre AM, Hajjar RJ, Harding SE, et al. Ca2+ cycling and new therapeutic approaches for heart failure. Circulation. 2010;121:822-830.
9. Gauthier C, Leblais V, Kobzik L, et al. The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest. 1998;102:1377-1384. (Pubitemid 28467566)
10. Skeberdis VA, Gendviliene V, Zablockaite D, et al. beta3-adrenergic receptor activation increases human atrial tissue contractility and stimulates the L-type Ca2+ current. J Clin Invest. 2008;118:3219-3227.
11. Kuschel M, Zhou YY, Spurgeon HA, et al. beta2-adrenergic cAMP signaling is uncoupled from phosphorylation of cytoplasmic proteins in canine heart. Circulation. 1999;99:2458-2465. (Pubitemid 29218244)
12. Zhu WZ, Wang SQ, Chakir K, et al. Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase Aindependent activation of Ca2+/calmodulin kinase II. J Clin Invest. 2003;111:617-625. (Pubitemid 36278580)
13. Engelhardt S, Hein L, Wiesmann F, Lohse MJ. Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci USA. 1999;96:7059-7064. (Pubitemid 29275009)
14. Liggett SB, Tepe NM, Lorenz JN, et al. Early and delayed consequences of beta(2)-adrenergic receptor overexpression in mouse hearts: critical role for expression level. Circulation. 2000;101:1707-1714. (Pubitemid 30196632)
15. Xiao RP, Zhang SJ, Chakir K, et al. Enhanced G(I) signaling selectively negates beta2-adrenergic receptor (AR)-but not beta1- AR-mediated positive inotropic effect in myocytes from failing rat hearts. Circulation. 2003;108:1633-1639. (Pubitemid 37187792)
16. Talan MI, Ahmet I, Xiao RP, Lakatta EG. beta(2) AR agonists in treatment of chronic heart failure: long path to translation. J Mol Cell Cardiol. 2010, In press
17. Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of beta -adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem. 2000;275:41447-41457. (Pubitemid 32054981)
18. Jurevicius J, Fischmeister R. cAMP compartmentalization is responsible for a local activation of cardiac Ca2+ channels by betaadrenergic agonists. Proc Natl Acad Sci USA. 1996;93:295-299.
19. DiPilato LM, Zhang J. Fluorescent protein-based biosensors: resolving spatiotemporal dynamics of signaling. Curr Opin Chem Biol. 2010;14:37-42.
20. Nikolaev VO, Bunemann M, Schmitteckert E, et al. Cyclic AMP imaging in adult cardiac myocytes reveals far-reaching beta1- adrenergic but locally confined beta2-adrenergic receptormediated signaling. Circ Res. 2006;99:1084-1091. (Pubitemid 44729932)
21. Nikolaev VO, Moshkov A, Lyon AR, et al. Beta2-adrenergic receptor redistribution in heart failure changes cAMP compartmentalization. Science. 2010; 327:1653-1657.
22. Zaccolo M. cAMP signal transduction in the heart: understanding spatial control for the development of novel therapeutic strategies. Br J Pharmacol. 2009;158:50-60.
23. Zaccolo M, Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science. 2002;295:1711-1715. (Pubitemid 34202906)
24. Mongillo M, McSorley T, Evellin S, et al. Fluorescence resonance energy transfer-based analysis of cAMP dynamics in live neonatal rat cardiac myocytes reveals distinct functions of compartmentalized phosphodiesterases. Circ Res. 2004;95:67-75. (Pubitemid 38931837)
25. Rochais F, Abi-Gerges A, Horner K, et al. A specific pattern of phosphodiesterases controls the cAMP signals generated by different Gs-coupled receptors in adult rat ventricular myocytes. Circ Res. 2006;98:1081-1088.
26. Richter W, Day P, Agrawal R, et al. Signaling from beta1- to beta2-adrenergic receptors is defined by differential interactions with PDE4. EMBO J. 2008;27:384-393. (Pubitemid 351161657)
27. Perry SJ, Baillie GS, Kohout TA, et al. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science. 2002;298:834-836. (Pubitemid 35231537)
28. Baillie GS, Sood A, McPhee I, et al. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi. Proc Natl Acad Sci USA. 2003;100:940-945. (Pubitemid 36183934)
29. Leroy J, Abi-Gerges A, Nikolaev VO, et al. Spatiotemporal dynamics of beta-adrenergic cAMP signals and L-type Ca2+ channel regulation in adult rat ventricular myocytes: role of phosphodiesterases. Circ Res. 2008; 102:1091-1100. (Pubitemid 351667863)
30. Abi-Gerges A, Richter W, Lefebvre F, et al. Decreased expression and activity of cAMP phosphodiesterases in cardiac hypertrophy and its impact on beta-adrenergic cAMP signals. Circ Res. 2009;105:784-792.
31. Ding B, Abe J, Wei H, et al. Functional role of phosphodiesterase 3 in cardiomyocyte apoptosis: implication in heart failure. Circulation. 2005;111:2469-2476. (Pubitemid 40696135)
32. Lehnart SE, Wehrens XH, Reiken S, et al. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell. 2005;123:25-35. (Pubitemid 41414526)
33. Sin YY, Edwards HV, Li X, et al. Disruption of the cyclic AMP phosphodiesterase-4 (PDE4)-HSP20 complex attenuates the betaagonist induced hypertrophic response in cardiac myocytes. J Mol Cell Cardiol. 2011, In press
34. Dodge KL, Khouangsathiene S, Kapiloff MS, et al. mAKAP assembles a protein kinase A/PDE4 phosphodiesterase cAMP signaling module. EMBO J. 2001;20:1921-1930. (Pubitemid 32397394)
35. Dodge-Kafka KL, Langeberg L, Scott JD. Compartmentalization of cyclic nucleotide signaling in the heart: the role of A-kinase anchoring proteins. Circ Res. 2006;98:993-1001.
36. Lygren B, Carlson CR, Santamaria K, et al. AKAP complex regulates Ca2+ re-uptake into heart sarcoplasmic reticulum. EMBO Rep. 2007;8:1061-1067. (Pubitemid 350042342)
37. McConnell BK, Popovic Z, Mal N, et al. Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinaseAphosphorylation, and troponin I proteolysis. J Biol Chem. 2009;284:1583-1592.
38. Kapiloff MS, Jackson N, Airhart N. mAKAP and the ryanodine receptor are part of a multi-component signaling complex on the cardiomyocyte nuclear envelope. J Cell Sci. 2001;114:3167-3176. (Pubitemid 32910471)
39. Carnegie GK, Soughayer J, Smith FD, et al. AKAP-Lbc mobilizes a cardiac hypertrophy signaling pathway. Mol Cell. 2008; 32:169-179.
40. Christian F, Szaszak M, Friedl S, et al. Small molecule AKAP/ PKA interaction disruptors that activate PKA interfere with compartmentalized cAMP signaling in cardiac myocytes. J Biol Chem. 2011, In press
41. Enserink JM, Christensen AE, de Rooij J, et al. A novel Epacspecific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol. 2002;4:901-906. (Pubitemid 35331366)
42. Breckler M, Berthouze M, Laurent AC, et al. Rap-linked cAMP signaling Epac proteins: compartmentalization, functioning and disease implications. Cell Signal. 2011, In press
43. Metrich M, Lucas A, Gastineau M, et al. Epac mediates betaadrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res. 2008;102:959-965. (Pubitemid 351591548)
44. Rehmann H, Wittinghofer A, Bos JL. Capturing cyclic nucleotides in action: snapshots from crystallographic studies. Nat Rev Mol Cell Biol. 2007;8:63-73. (Pubitemid 46012015)
45. Metrich M, Berthouze M, Morel E, et al. Role of the cAMPbinding protein Epac in cardiovascular physiology and pathophysiology. Pflugers Arch. 2010;459:535-546.
46. Morel E, Marcantoni A, Gastineau M, et al. cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ Res. 2005;97:1296-1304.
47. Ulucan C, Wang X, Baljinnyam E, et al. Developmental changes in gene expression of Epac and its upregulation in myocardial hypertrophy. Am J Physiol Heart Circ Physiol. 2007;293:H1662-H1672. (Pubitemid 47367213)
48. Metrich M, Laurent AC, Breckler M, et al. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signaling pathway. Cell Signal. 2010; 22:1459-1468.
49. Pereira L, Metrich M, Fernandez-Velasco M, et al. The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/ calmodulin kinase signaling pathway in rat cardiac myocytes. J Physiol. 2007;583:685-694. (Pubitemid 47343498)
50. Kwak HJ, Park KM, Choi HE, et al. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways. Cell Signal. 2008;20:803-814.
51. Yokoyama U, Patel HH, Lai NC, et al. The cyclic AMP effector Epac integrates pro- and anti-fibrotic signals. Proc Natl Acad Sci USA. 2008;105:6386-6391. (Pubitemid 351758355)
52. Somekawa S, Fukuhara S, Nakaoka Y, et al. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ Res. 2005;97:655-662. (Pubitemid 41416334)
53. Cazorla O, Lucas A, Poirier F, et al. The cAMP binding protein Epac regulates cardiac myofilament function. Proc Natl Acad Sci USA. 2009;106:14144-14149.
54. Dodge-Kafka KL, Soughayer J, Pare GC, et al. The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature. 2005;437:574-578. (Pubitemid 41613557)
55. Sehrawat S, Ernandez T, Cullere X, et al. AKAP9 regulation of microtubule dynamics promotes Epac1-induced endothelial barrier properties. Blood. 2011;117:708-718.
56. Gloerich M, Ponsioen B, Vliem MJ, et al. Spatial regulation of cyclic AMP-Epac1 signaling in cell adhesion by ERM proteins. Mol Cell Biol. 2010;30:5421-5431.